Labeler
Avyxa Pharma, LLC NDC Codes
Avyxa Pharma, LLC lists 29 finished drug products in the FDA NDC Directory under NDC labeler code 83831.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Vykoura, Frindovyx, Cyclophosphamide, Docivyx, Avopef, Favlyxa, Kyxata, Avgemsi, Pemetrexed Dipotassium, Axtle, Navitrux, Cligavyx, Bendamustine Hydrochloride, Lutrate Depot, posfrea
- Active ingredients
- Cyclophosphamide, Pemetrexed, Leucovorin calcium, Docetaxel, Etoposide, Fluorouracil, Carboplatin, Gemcitabine hydrochloride, Fosaprepitant dimeglumine, Fulvestrant, Bendamustine hydrochloride, Palonosetron hydrochloride
- NDC labeler codes
- 83831
- Strengths
- Fluorouracil 25 mg/mL; Gemcitabine hydrochloride 38 mg/mL; Cyclophosphamide 500 mg/mL; Cyclophosphamide 1 g/2mL; Cyclophosphamide 2 g/4mL; Pemetrexed 500 mg/20mL; Pemetrexed 100 mg/4mL; Etoposide 500 mg/25mL; Fosaprepitant dimeglumine 150 mg/5mL; Fulvestrant 250 mg/5mL; Bendamustine hydrochloride 100 mg/4mL; Etoposide 100 mg/5mL; Leucovorin calcium 350 mg/35mL; Leucovorin calcium 50 mg/5mL; Leucovorin calcium 500 mg/50mL; Carboplatin 80 mg/8mL; Carboplatin 500 mg/50mL; Palonosetron hydrochloride .25 mg/5mL; Docetaxel 80 mg/8mL; Docetaxel 20 mg/2mL
- Dosage forms
- Injection, Injection, Solution, Injection, Powder, Lyophilized, For solution, Kit
- Routes
- Intravenous, Intramuscular
- Drug classes (FDA established)
- Nucleoside Metabolic Inhibitor, Folate Analog Metabolic Inhibitor, Folate Analog, Microtubule Inhibitor, Topoisomerase Inhibitor, Platinum-based Drug, Substance P/Neurokinin-1 Receptor Antagonist, Estrogen Receptor Antagonist, Alkylating Drug, Serotonin-3 Receptor Antagonist
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 29
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Avopefetoposide | Etoposide 500 mg/25mL | InjectionIntravenous | 83831-145 | 83831-0145-25 | — |
| Navitruxfosaprepitant | Fosaprepitant dimeglumine 150 mg/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | 83831-153 | 83831-0153-01 | — |
| Favlyxafluorouracil | Fluorouracil 25 mg/mL | Injection, SolutionIntravenous | 83831-164 | 83831-0164-10 | — |
| Cligavyxfulvestrant | Fulvestrant 250 mg/5mL | InjectionIntramuscular | 83831-159 | 83831-0159-02 | — |
| Bendamustine Hydrochloride | Bendamustine hydrochloride 100 mg/4mL | InjectionIntravenous | 83831-183 | 83831-0183-04 | — |
| Favlyxafluorouracil | Fluorouracil 25 mg/mL | Injection, SolutionIntravenous | 83831-143 | 83831-0143-01 | — |
| Avopefetoposide | Etoposide 100 mg/5mL | InjectionIntravenous | 83831-144 | 83831-0144-05 | — |
| Vykouraleucovorin calcium | Leucovorin calcium 350 mg/35mL | InjectionIntramuscular, Intravenous | 83831-148 | 83831-0148-35 | — |
| Vykouraleucovorin calcium | Leucovorin calcium 50 mg/5mL | InjectionIntramuscular, Intravenous | 83831-147 | 83831-0147-05 | — |
| Vykouraleucovorin calcium | Leucovorin calcium 500 mg/50mL | InjectionIntramuscular, Intravenous | 83831-149 | 83831-0149-50 | — |
| Kyxatacarboplatin | Carboplatin 80 mg/8mL | InjectionIntravenous | 83831-141 | 83831-0141-08 | — |
| Kyxatacarboplatin | Carboplatin 500 mg/50mL | InjectionIntravenous | 83831-142 | 83831-0142-50 | — |
| Avgemsigemcitabine | Gemcitabine hydrochloride 38 mg/mL | Injection, SolutionIntravenous | 83831-123 | 83831-0123-01 | — |
| Avgemsigemcitabine | Gemcitabine hydrochloride 38 mg/mL | Injection, SolutionIntravenous | 83831-124 | 83831-0124-01 | — |
| Lutrate Depotleuprolide acetate | — | Kit | 83831-134 | 83831-0134-01 | — |
| Frindovyxcyclophosphamide | Cyclophosphamide 500 mg/mL | InjectionIntravenous | 83831-119 | 83831-0119-01 | — |
| Frindovyxcyclophosphamide | Cyclophosphamide 1 g/2mL | InjectionIntravenous | 83831-120 | 83831-0120-02 | — |
| Frindovyxcyclophosphamide | Cyclophosphamide 2 g/4mL | InjectionIntravenous | 83831-121 | 83831-0121-04 | — |
| Pemetrexed Dipotassium | Pemetrexed 500 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | 83831-112 | 83831-0112-01 | — |
| Pemetrexed Dipotassium | Pemetrexed 100 mg/4mL | Injection, Powder, Lyophilized, For solutionIntravenous | 83831-111 | 83831-0111-01 | — |
| Axtlepemetrexed | Pemetrexed 100 mg/4mL | Injection, Powder, Lyophilized, For solutionIntravenous | 83831-131 | 83831-0131-01 | — |
| Axtlepemetrexed | Pemetrexed 500 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | 83831-132 | 83831-0132-01 | — |
| posfreapalonosetron | Palonosetron hydrochloride .25 mg/5mL | Injection, SolutionIntravenous | 83831-105 | 83831-0105-01 | — |
| Cyclophosphamide | Cyclophosphamide 2 g/4mL | InjectionIntravenous | 83831-118 | 83831-0118-04 | — |
| Cyclophosphamide | Cyclophosphamide 500 mg/mL | InjectionIntravenous | 83831-116 | 83831-0116-01 | — |
| Cyclophosphamide | Cyclophosphamide 1 g/2mL | InjectionIntravenous | 83831-117 | 83831-0117-02 | — |
| Docivyxdocetaxel | Docetaxel 80 mg/8mL | Injection, SolutionIntravenous | 83831-102 | 83831-0102-08 | — |
| Docivyxdocetaxel | Docetaxel 20 mg/2mL | Injection, SolutionIntravenous | 83831-101 | 83831-0101-02 | — |
| Docivyxdocetaxel | Docetaxel 160 mg/16mL | Injection, SolutionIntravenous | 83831-103 | 83831-0103-16 | — |
Avyxa Pharma, LLC: common questions
- What is Avyxa Pharma, LLC's NDC labeler code?
- 83831. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Avyxa Pharma, LLC?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.